Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Nonobstructive Heart Enlargement Responds to Aficamten

(MedPage Today) -- Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM) in a large, double-blind, placebo-controlled trial...

Nonobstructive Heart Enlargement Responds to Aficamten

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 28 August →